Im Jong-hoon Increases Hanmi Science Stake to 13.65% and Signs 82 Billion Won Block Sale with Now IB22 Fund - Strengthens Management Influence
Im Jong-hoon a registered executive of Hanmi Science increased his stake from 13.43% to 13.65% as of the reporting date, mainly due to open market purchases of 151,109 shares by special relation DXVX Co., Ltd.
Im Jong-hoon signed a stock purchase agreement with Now IB22 Fund for 1,709,788 shares worth approximately 82 billion won at a price of 48,000 won per share, a 56.6% premium to the current market price. This large-scale block sale is aimed at influencing management and reveals a complex financing structure alongside existing loans and repurchase agreements.
The filer stated his purpose is to exercise influence over key corporate matters including director appointments and capital changes.
[AI Summary]Im Jong-hoon's stake increase and premium block sale signal his commitment to strengthen management control, but the heavy use of personal loans and collateral agreements poses a risk of margin calls if the stock price falls. The premium is a positive sign, but investors should check for any hidden put option clauses.